PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30850583-0	2019	Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.	ARQ 197	19-29	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	68-73	
30850583-11	2019	Synergistic activation of the JNK/c-jun pathway was demonstrated after Tivantinib treatment.	ARQ 197	71-81	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	34-39	
30850583-14	2019	The synergistic activation of the JNK/c-jun pathway contributed to the elevated apoptosis in CC cells via treatment with Tivantinib.	ARQ 197	121-131	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	38-43